National Institutes of Health: all 11,571 studies

Page 30 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1/2Results posted
• Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal TumorTerminatedNCT00324987Phase 3Results posted
• Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00324870Phase 1/2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryCompletedNCT00324805Phase 3Results posted
• Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney CancerTerminatedNCT00324740Phase 1/2Results posted
• Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverCompletedNCT00323414Phase 2Results posted
• NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)CompletedNCT00322465Phase 2Results posted
• Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerCompletedNCT00321893Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00321594Phase 1/2Results posted
• LMB-2 to Treat Hairy Cell LeukemiaCompletedNCT00321555Phase 2Results posted
• Withdrawal of Immunosuppression in Pediatric Liver Transplant RecipientsCompletedNCT00320606Phase 1Results posted
• Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaCompletedNCT00314106Phase 2Results posted
• Oxaliplatin and Topotecan in Advance Ovarian CancerTerminatedNCT00313612Phase 2Results posted
• Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaCompletedNCT00313586Phase 2Results posted
• Effect of LY686017 on Alcohol CravingCompletedNCT00310427Phase 2Results posted
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)Active, not recruitingNCT00310180Phase 3Results posted
• Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00309946Phase 2Results posted
• Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)CompletedNCT00309387Phase 3Results posted
• Effects of a Uridine Supplement on HIV Infected Adults With LipoatrophyCompletedNCT00307164Phase 2/3Results posted
• Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesCompletedNCT00307125Phase 2Results posted
• OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular DegenerationCompletedNCT00306488Phase 2Results posted
• Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryCompletedNCT00305877Phase 2Results posted
• Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00305864Phase 1/2Results posted
• Vorinostat in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00305773Phase 2Results posted
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
• Effectiveness of Bupropion for Smokers Recovering From Alcohol DependenceCompletedNCT00304707Phase 3Results posted
• Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaTerminatedNCT00303966Phase 2Results posted
• PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's LymphomaCompletedNCT00303953Phase 2Results posted
• AZD2171 in Treating Patients With Refractory Metastatic Kidney CancerTerminatedNCT00303862Phase 2Results posted
• Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial NeoplasiaCompletedNCT00303823Phase 2Results posted
• Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)CompletedNCT00303446Phase 2Results posted
• Lovastatin for the Treatment of Mildly Active Rheumatoid ArthritisTerminatedNCT00302952Phase 2Results posted
• Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain TumorsCompletedNCT00302159Phase 2Results posted
• Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00301964Phase 2Results posted
• Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential TumorsCompletedNCT00301756Phase 2Results posted
• High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian InfluenzaCompletedNCT00298233Phase 2Results posted
• A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following PortoenterostomyCompletedNCT00294684Not applicableResults posted
• Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00290810Phase 2Results posted
• Genistein in Preventing Breast Cancer in Women at High Risk for Breast CancerCompletedNCT00290758Phase 2Results posted
• CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00290472Phase 2Results posted
• Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914CompletedNCT00290251Phase 2Results posted
• High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) StudyCompletedNCT00288626Phase 2Results posted
• Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT00288067Phase 1/2Results posted
• Use of Infliximab for the Treatment of Pemphigus VulgarisCompletedNCT00283712Phase 2Results posted
• HALT Progression of Polycystic Kidney Disease Study ACompletedNCT00283686Phase 3Results posted
• Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By SurgeryCompletedNCT00281957Phase 2Results posted
• Efalizumab to Treat UveitisCompletedNCT00280826Phase 1Results posted
• Atorvastatin to Treat Pulmonary SarcoidosisCompletedNCT00279708Phase 2Results posted
• Rituximab in New Onset Type 1 DiabetesCompletedNCT00279305Phase 2Results posted
• Vorinostat in Treating Patients With Kidney CancerCompletedNCT00278395Phase 2Results posted
• Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00278343Phase 2Results posted
• AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00275028Phase 2Results posted
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem TumorsCompletedNCT00275002Phase 2Results posted
• Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaCompletedNCT00273910Phase 2Results posted
• Bevacizumab for Recurrent Malignant GliomaCompletedNCT00271609Phase 2Results posted
• Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVCompletedNCT00270296Phase 2Results posted
• Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug UsersTerminatedNCT00270257Phase 3Results posted
• Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAARTCompletedNCT00270205Phase 1/2Results posted
• Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
• Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib MalateActive, not recruitingNCT00265798Phase 2Results posted
• Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT00262925Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3Results posted
• Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast CancerCompletedNCT00262834Phase 2Results posted
• Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical CancerTerminatedNCT00262821Phase 3Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerCompletedNCT00258349Phase 1/2Results posted
• Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's LymphomaCompletedNCT00253630Phase 2Results posted
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT00253370Phase 2Results posted
• Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid CancerCompletedNCT00251316Phase 2Results posted
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2Results posted
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaCompletedNCT00245102Phase 2Results posted
• AZD2171 in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00245063Phase 2Results posted
• A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)CompletedNCT00244881Phase 2Results posted
• S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryCompletedNCT00243074Phase 2Results posted
• AZD2171 in Treating Patients With Recurrent or Stage IV MelanomaCompletedNCT00243061Phase 2Results posted
• Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation RecipientsCompletedNCT00240994Phase 2Results posted
• Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-InfectionTerminatedNCT00239733Phase 4Results posted
• PsA Treatment With hOKT3γ1 (Ala-Ala)TerminatedNCT00239720Phase 2Results posted
• Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder CancerCompletedNCT00238420Phase 1/2Results posted
• Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00238303Phase 2Results posted
• Sorafenib in Treating Patients With Advanced or Recurrent Uterine CancerCompletedNCT00238121Phase 2Results posted
• Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan AnemiaCompletedNCT00229619Phase 2Results posted
• Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By SurgeryCompletedNCT00227760Phase 2Results posted
• Lenalidomide and Prednisone in Treating Patients With MyelofibrosisCompletedNCT00227591Phase 2Results posted
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedNCT00224874Phase 2Results posted
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerCompletedNCT00217737Phase 3Results posted
• S0505 Sorafenib in Treating Patients With Advanced Soft Tissue SarcomasCompletedNCT00217620Phase 2Results posted
• A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic SyndromeCompletedNCT00217594Phase 2Results posted
• Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00217399Phase 1/2Results posted
• Intensity Modulated Radiation Therapy for Prostate CancerCompletedNCT00214422Early Phase 1Results posted
• Conservative Treatment of Postprostatectomy IncontinenceCompletedNCT00212264Not applicableResults posted
• Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)CompletedNCT00201240Phase 2Results posted
• Identifying the Anti-Blood-Clotting Compounds in GarlicCompletedNCT00200785Not applicableResults posted
• Alemtuzumab to Treat Severe Aplastic AnemiaCompletedNCT00195624Phase 2Results posted
• Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerCompletedNCT00182767Phase 1/2Results posted
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00182689Phase 2Results posted
• Docetaxel Alone or in Combination With Vaccine to Treat Breast CancerCompletedNCT00179309Phase 2Results posted
• Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated MeningitisCompletedNCT00145249Phase 2Results posted
• Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) TransplantationCompletedNCT00141037Phase 1/2Results posted

← National Institutes of Health overview and focus areas